Commerzbank Aktiengesellschaft’s Moderna MRNA Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$407K	Sell	5,814 -4,102	-41%	-$212K	0.01%	274
2026 Q1	$504K	Buy	+9,916	New	+$463K	0.01%	261
2025 Q2	–	Sell	-12,261	Closed	-$348K	–	365
2025 Q1	$348K	Hold	12,261	–	–	0.01%	272
2024 Q4	$483K	Buy	12,261 +6,174	+101%	+$295K	0.01%	223
2024 Q3	$407K	Buy	6,087 +537	+10%	+$49.3K	0.01%	212
2024 Q2	$660K	Buy	5,550 +93	+2%	+$11.8K	0.02%	139
2024 Q1	$582K	Buy	5,457 +400	+8%	+$40.3K	0.02%	141
2023 Q4	$503K	Buy	5,057 +2,528	+100%	+$213K	0.02%	115
2023 Q3	$262K	Buy	+2,529	New	+$282K	0.01%	130

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Commerzbank Aktiengesellschaft's MRNA Position: Q2 2026 in Review

Commerzbank Aktiengesellschaft reduced its Moderna (MRNA) stake by 41% in Q2 2026, selling an estimated $212K and leaving 5,814 shares worth $407K. The position accounts for 0.01% of the portfolio, ranked #274.

Commerzbank Aktiengesellschaft first reported a position in MRNA in Q3 2023 and has held it in 9 quarters since. The position peaked at $660K in Q2 2024. 777 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Commerzbank Aktiengesellschaft held 5,814 shares of Moderna worth $407K as of Q2 2026.
Commerzbank Aktiengesellschaft sold 4,102 Moderna shares in Q2 2026, an estimated $212K.
Moderna made up 0.01% of Commerzbank Aktiengesellschaft's portfolio in Q2 2026, its #274 holding.
Commerzbank Aktiengesellschaft first reported a position in Moderna in Q3 2023 and has held it in 9 quarters since.
Commerzbank Aktiengesellschaft's Moderna position peaked at $660K in Q2 2024.
777 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q2 2026, filed 7 Aug 2026.